Kohler, Dr Janice

BSc, FRCP, FRCPCH Jan Kohler

Speciality

Paediatrics

Sub-speciality

Paediatric Oncology

Training and Education

Bristol University
Oncology at Great Ormond Street Hospital

Experience

Dr Kohler has worked for Southampton University Hospitals Trust since January 1984. 

Experience in every subspecialty in paediatric oncology
Particular interest in neuroblastoma
Principal Investigator for numerous clinical trials

Key achievements

Setting up regional Paediatric Oncology service

Executive of Children’s Cancer and Leukaemia Group
Chair CCLG Clinical Research Governance Group
Past Chair CCLG Neuroblastoma Study Group
Previous Regional Advisor for Paediatrics

 

Research

A Randomised trial of 13 Cis retinoic acid in children with advanced neuroblastoma after high dose therapy.  Kohler JA, Imeson J, Ellershaw C, Lie SO.   Br. J. Cancer 2000;83:1124-1127.

Response to N7 induction chemotherapy in children more than one year of age diagnosed with metastatic neuroblastoma treated in UKCCSG centres. Kohler JA, Ellershaw C, Machin D. Pediatr Blood Cancer 2007; 49: 234-239

Diclofenac mediated derangement of neuroblastoma cell lipidomic profiles is accompanied by increased phosphatidylcholine biosynthesis. Hunt AN, Macken M, Koster G, Kohler JA and Postle AD. Advan Enzyme Regul 2008; 48: 74-87.